Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec;4(12):e964-e965.
doi: 10.1016/S2666-5247(23)00321-X. Epub 2023 Nov 3.

Emerging bedaquiline-resistant tuberculosis

Christoph Lange  1 , Anca Vasiliu  2 , Anna M Mandalakas  3
Affiliations
Comment

Emerging bedaquiline-resistant tuberculosis

Christoph Lange et al. Lancet Microbe. 2023 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CL is supported by the German Center for Infection Research (TTU 02.709); has received speaker's honoraria from Insmed, Gilead, and Janssen; and is a member of the Data Safety Board of trials from Medicines sans Frontiers, outside of the scope of this work. AMM was a member of the Data Safety Board of trials from Janssen. AV declares no competing interests.

Comment on

References

    1. WHO. Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
    1. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet 2022; 399:629–55. - PMC - PubMed
    1. von Groote-Bidlingmaier F, Patientia R, Sanchez E, et al. Efficacy and safety of delaman id in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial. Lancet Respir Med 2019; 7:249–59. - PubMed
    1. Schnippel K, Ndjeka N, Maartens G, et al. Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study. Lancet Respir Med 2018; 6: 699–706. - PubMed
    1. WHO. WHO consolidated guidelines on tuberculosis. Module 4: treatment—drug-resistant tuberculosis treatment, 2022 update. Geneva: World Health Organization, 2022. - PubMed

Publication types

MeSH terms